Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41571-020-00448-y http://scihub22266oqcxt.onion/10.1038/s41571-020-00448-y 33139895!7604917!33139895     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33139895&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nat+Rev+Clin+Oncol 2021 ; 18 (1): 7-8 Nephropedia Template TP {{tp|p=33139895|t=2021. Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19 |pdf=|usr=}}{{33139895}} gab.com Text Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19 JO: Nat Rev Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33139895 #FOAvip Randomized controlled trials designed to test cancer therapies often fail to clarify effectiveness in real-world settings. Herein, we explore lessons for trial development in oncology that can be learnt from the large-cohort, pragmatic RECOVERY trial involving patients hospitalized with COVID-19. Twit Text FOAVip Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19 ????Nat Rev Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33139895 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33139895 #FOAvip English Wikipedia <ref>{{Cite pmid|33139895}}</ref> Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19 #MMPMID33139895 Banerjee R; Prasad V Nat Rev Clin Oncol 2021[Jan]; 18 (1): 7-8 PMID33139895show ga Randomized controlled trials designed to test cancer therapies often fail to clarify effectiveness in real-world settings. Herein, we explore lessons for trial development in oncology that can be learnt from the large-cohort, pragmatic RECOVERY trial involving patients hospitalized with COVID-19. |*COVID-19 Drug Treatment[MESH] |*Dexamethasone/therapeutic use[MESH] |Anti-Inflammatory Agents/therapeutic use[MESH] |Humans[MESH] |Inpatients[MESH] |Oncologists[MESH]Pragmatic trials with prespecified subgroups: what oncologists can lea(epmc).pdf DeepDyve Pubget Overpricing